======= TAF1C ======= == Gene Information == * **Official Symbol**: TAF1C * **Official Name**: TATA-box binding protein associated factor, RNA polymerase I subunit C * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9013|9013]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15572|Q15572]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAF1C&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAF1C|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604905|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (preinitiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1/TIF-IB with the rDNA promoter. SL1/TIF-IB is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA. Formation of SL1/TIF-IB excludes the association of TBP with TFIID subunits. Recruits RNA polymerase I to the rRNA gene promoter via interaction with RRN3. {ECO:0000269|PubMed:11250903, ECO:0000269|PubMed:15970593}. No Pfam Domain information is available for this gene. |RNA polymerase I CORE element sequence-specific DNA binding| |RNA polymerase I preinitiation complex assembly| |transcription elongation from RNA polymerase I promoter| |transcription preinitiation complex assembly| |termination of RNA polymerase I transcription| |regulation of transcription by RNA polymerase I| |transcription initiation from RNA polymerase I promoter| |transcription by RNA polymerase I| |positive regulation of gene expression, epigenetic| |DNA-templated transcription, termination| |DNA-templated transcription, elongation| |fibrillar center| |protein-DNA complex assembly| |DNA-templated transcription, initiation| |regulation of gene expression, epigenetic| |protein-DNA complex subunit organization| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |cellular protein-containing complex assembly| |nucleolus| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |protein-containing complex subunit organization| |positive regulation of gene expression| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|-1.98| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|-1.97| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-1.85| |[[:results:exp130|JQ1 0.01μM R03 exp130]]|-1.79| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-1.76| |[[:results:exp121|Golgicide-A 2μM R03 exp121]]|-1.71| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.497| Global Fraction of Cell Lines Where Essential: 706/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|25/25| |breast|31/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|13/15| |kidney|21/21| |liver|18/20| |lung|75/75| |lymphocyte|14/14| |ovary|24/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|7/7| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|27/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 965 * **Expression level (log2 read counts)**: 6.45 {{:chemogenomics:nalm6 dist.png?nolink |}}